Skip to content
WEIGHT LOSS · CLINICALLY SUPERVISED

Lose weight. Keep it off.

Start eligibility for current pharmacist-led pathways. The oral GLP-1 tablet route is updates-only until the planned Q4 2026 launch.

Check current eligibilityJoin tablet updates
Current pathways live · oral GLP-1 tablet updates
GPhC-registered pharmacist review
Pharmacy partner support where applicable.
Pharmacist-led throughout
Prescribing and supply decisions are recorded under pharmacy governance.
Tracked UK delivery
Discreet packaging, with cold-chain controls where needed.
OUR PROMISE
A clinically supervised weight loss service, run by UK pharmacists. You’re never left to figure this out alone.
DISPENSING PARTNER

In partnership with Cornwells Chemists.
Established 1835.

Nuora's prescriptions are dispensed by Cornwells Chemists — a British pharmacy group whose dispensing lineage stretches back to 1835. A modern clinical service, dispatched under 190 years of pharmaceutical standards. Cold-chain where needed, discreet packaging, and the same GPhC oversight that every Cornwells pharmacy operates under.

Dispensing since
1835
GPhC registered
Yes
UK cold-chain
MHRA-compliant
Cornwells Chemists — Specialists in Healthcare since 1835
Dispensing Partner · Since 1835
Treatments

Current care and future tablets,
with tablet updates clearly marked.

Begin the assessment for current prescription or capsule pathways. The oral GLP-1 tablet route is a Q4 2026 updates list only; no tablet prescribing starts from this page today.

  • Prescription weight-management pathway, photographed editorially on a mineral cream surface
    CURRENT PROGRAMME

    Pharmacist-reviewed pathway

    Current medication options · Ongoing pharmacist care

    Start here if you want assessment for weight care available through Nuora now.

    From £149/month

    Check current eligibilityTreatment details

    Prescription only. Subject to clinician approval.

  • Advanced prescription weight-management pathway, photographed editorially on a mineral cream surface
    CURRENT PROGRAMME

    Higher-support pathway

    Enhanced clinical monitoring · Pharmacist-led reviews

    A more closely monitored pathway; higher-dose care is a separate tier if appropriate.

    From £199/month; higher-dose tier shown in Pricing

    Check current eligibilityTreatment details

    Prescription only. Subject to clinician approval.

  • Orlos by Nuora orlistat 60 mg capsule bottle, photographed editorially on a mineral cream surface
    CURRENT CAPSULE OPTION

    Orlos®

    Orlistat 60 mg · Daily oral capsule

    A current pharmacist-supervised oral capsule option for adults who may be suitable.

    From £39/month

    Check current eligibilityTreatment details
  • Planned oral GLP-1 tablet-based weight-management pathway, editorial product photograph
    ORAL GLP-1 UPDATES

    Oral tablet updates

    Planned oral GLP-1 tablet · Not prescribed today

    Join launch updates; today’s assessment reviews current pharmacist-led pathways.

    Launch updates only

    Join tablet updatesHow review works

    Updates only. No prescribing or supply today.

Important safety information — Some clinical care pathways can cause side effects, most commonly digestive symptoms. Read the full patient information leaflet before starting treatment, and report any side effect to the MHRA Yellow Card scheme. Treatment is only dispensed after a NUORA pharmacist has confirmed it is safe for you.

DAY-TO-DAY CARE

Every touchpoint, in one place.

From your first message to your long-term plan adjustments, everything you need sits in your Nuora account. Chat, video, records, scheduling — no apps to install just for a prescription refill.

Nuora Care
Pharmacist-reviewed
MESSAGING

Care, whenever you need it.

Always on. Every reply pharmacist-reviewed.

End-to-end encrypted
12:04
SIGNALEXCELLENT
VIDEO CONSULTATIONS

A pharmacist, face-to-face.

End-to-end encrypted. Booked in minutes.

Clinical Timeline
APRIL 2026
17 APR
Dose titration to 0.5 mg
14 APR
Side-effect check passed
10 APR
Week 1 check-in
03 APR
Dose 0.25 mg shipped
02 APR
Pharmacist review
CLINICAL TIMELINE

Your full record, always visible.

Yours to read, share, or export.

April 2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Pharmacist check-in · 17 Apr · 10:00
15 minutes · secure video
SCHEDULING

Your appointments, your calendar.

Your next check-in, one tap away.

HOW CARE UNFOLDS

Six stages. One pharmacist. Every step.

  1. A full clinical intake, not a five-question quiz.

BUILT BY PHARMACISTS

Built by pharmacists. Designed for the long game.

Pharmacy partner support. Prescribing and supply decisions are recorded under pharmacy governance.

01
GPhC
Pharmacy Partner Support
Cornwells Chemists partnership · pharmacist oversight of every prescription
02
Gate
Clinical Review Gate
No prescribing, payment capture, or supply before a GPhC-registered clinician is assigned and recorded
03
1835
Pharmaceutical Lineage
Dispensing partnership with Cornwells Chemists, established 1835
YOUR CLINICAL TEAM

Named clinical governance.
No anonymous approvals.

The eligibility assessment can be completed online, but no prescribing, dispensing, or supply decision is made until accountable GPhC-registered clinical cover is assigned, recorded, and shown in the patient record.

accountablereview
Required before treatment

Superintendent Pharmacist

MPharm · GPhC · Independent Prescriber

The named Superintendent Pharmacist must be recorded before any prescribing, dispensing, or supply decision is made.

accountablereview
Required before treatment

Responsible Pharmacist

MPharm · GPhC registered

A Responsible Pharmacist must be on duty before any clinical review can move into medicine supply.

accountablereview
Required before treatment

Clinical Lead

Independent Prescriber · GPhC registered

The clinical lead owns protocol approval, escalation review, and launch readiness for each care pathway.

PRICING

Weight Loss care, honestly priced.

Medication (if prescribed), coaching, pharmacist reviews, delivery

Treatment cards show pathway starting points. The higher-support pathway can include a higher-dose pricing tier when a prescriber decides it is clinically appropriate.

Consultation
£49 one-off

Weight Loss Consultation. One-off clinician review and prescribing assessment.

Check current eligibility
  • Complete 20-question medical questionnaire
  • Clinical review assigned before prescribing or supply
  • Contraindications screened (pregnancy, MEN2, pancreatitis history)
Ongoing care
£149/month

Weight Loss - Starter. Ongoing pricing depends on the prescribed care plan.

Check current eligibility
  • Current pharmacist-reviewed options
  • Nutrition, movement, sleep coaching
  • Oral GLP-1 tablet launch updates
  • Initial consultation £49
  • Ongoing treatment from £149 per month
Higher-support care
£349/month

Weight Loss - High Dose. Ongoing pricing depends on the prescribed care plan.

Check current eligibility
  • Everything in Ongoing care
  • Higher-dose prescribing where clinically appropriate
  • Priority pharmacist response on dose adjustments
No joining feesCancel anytimeNext-day delivery when approved
COMMON QUESTIONS

Questions, answered honestly.

Still not sure? Our pharmacist team answer directly in the assessment.

Adults with BMI ≥27 (with comorbidities) or ≥30 seeking medical weight management.

Ready when you are

Start with a clear eligibility assessment.

Complete the clinical assessment online, text START WEIGHT to 07307 285 724, or WhatsApp us and the intake starts there. Prescribing, payment capture, and supply only proceed after accountable GPhC‑registered clinical review is assigned and recorded.

Check current eligibilityWhatsApp START WEIGHT£0 to complete · Cancel anytime

Was this page useful?

Your answer helps us improve the service journey.

Check current eligibility